Arcutis Biotherapeutics (ARQT) appointed Christopher Peetz to its Board of Directors, effective July 15, 2026. The announcement is a governance update with no disclosed financial targets or operational changes.
Arcutis Biotherapeutics (ARQT) appointed Christopher Peetz to its Board of Directors, effective July 15, 2026. The announcement is a governance update with no disclosed financial targets or operational changes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
